CVS Health Corporation (NYSE:CVS) 2022 Barclays Healthcare Conference March 15, 2022 8:00 AM ET
Company Participants
Shawn Guertin - CFO
Conference Call Participants
Steven Valiquette - Barclays
Steven Valiquette
Welcome everyone to day one of the Barclays Global Healthcare Conference. I’m Steven Valiquette the Healthcare Services Analyst here at Barclays. Pleased to kick things off with CVS Health. With us from the Company is Shawn Guertin, Company’s CFO. This will be a fireside chat. So, I think with that, I guess we’ll just dive right in.
Shawn Guertin
Sure.
Question-and-Answer Session
Q - Steven Valiquette
Okay, great. So, maybe we’ll kick off with some topics, this first question kind of ties to a lot of the parts of the overall company. Maybe just some of your latest thoughts around the COVID impact from here on out. It’s been pretty topical for investors. Obviously, January was a pretty clear trend with COVID being pretty high. It’s obviously tapered off since then. And that has impact, both on the COVID and non-COVID utilizations. Now, over a few months out from that most recent case resurgence, maybe just offer any additional color on that trajectory of COVID-driven trends in both, the retail and the HCB segments.
Shawn Guertin
Great. Thank you, Steve, and good morning, everyone. Just one housekeeping, as I have no slides, I do just want to point out that I will be making forward statements that I’d ask that you consult our description of our Risk Factors that are contained in our most recent 10-K. But, back to COVID.
So, this obviously, remains sort of the biggest item in terms of forecasting that is creating uncertainty to your point. And I think before we go into details, it’s always important to remember that we really had two businesses that have just been going in
- Read more current CVS analysis and news
- View all earnings call transcripts